Cencora, Inc. (COR) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Medical - Distribution
EV/EBITDA
↑
13.35
↑+23% vs avg
5yr avg: 10.87
30Y Low7.0·High19.8
P/FCF
↑
18.55
↑+35% vs avg
5yr avg: 13.77
30Y Low5.6·High41.0
P/B Ratio
↓
34.18
↓-71% vs avg
5yr avg: 118.23
30Y Low1.4·High99.4
ROE
↓
122.7%
↑-61% vs avg
5yr avg: 317.1%
30Y Low-291%·High473%
Debt/EBITDA
↓
1.63
+4% vs avg
5yr avg: 1.57
30Y Low1.0·High5.6
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
COR Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Cencora, Inc. trades at 38.4x earnings, 56% above its 5-year average of 24.6x, sitting at the 89th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.2x, the stock trades at a premium of 73%. On a free-cash-flow basis, the stock trades at 18.6x P/FCF, 35% above the 5-year average of 13.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $59.5B | $61.0B | $45.1B | $36.8B | $28.6B | $24.9B | $19.8B | $17.4B | $20.3B | $18.3B | $18.3B |
| Enterprise Value | $62.8B | $64.3B | $46.3B | $39.0B | $30.9B | $29.0B | $19.4B | $18.2B | $22.1B | $19.3B | $19.1B |
| P/E Ratio → | 38.43 | 39.26 | 29.89 | 21.10 | 16.83 | 16.16 | — | 20.38 | 12.25 | 50.46 | 12.78 |
| P/S Ratio | 0.19 | 0.19 | 0.15 | 0.14 | 0.12 | 0.12 | 0.10 | 0.10 | 0.12 | 0.12 | 0.12 |
| P/B Ratio | 34.18 | 34.92 | 57.30 | 55.26 | 401.04 | 42.61 | — | 5.83 | 6.66 | 8.67 | 8.57 |
| P/FCF | 18.55 | 19.02 | 15.04 | 10.66 | 12.95 | 11.17 | 10.80 | 8.58 | 18.90 | 17.93 | 6.73 |
| P/OCF | 15.36 | 15.74 | 12.94 | 9.41 | 10.57 | 9.34 | 8.99 | 7.44 | 14.40 | 12.32 | 5.74 |
P/E links to full P/E history page with 30-year chart
COR EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Cencora, Inc.'s enterprise value stands at 13.3x EBITDA, 23% above its 5-year average of 10.9x. This is roughly in line with the Healthcare sector median of 14.0x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.20 | 0.16 | 0.15 | 0.13 | 0.14 | 0.10 | 0.10 | 0.13 | 0.13 | 0.13 |
| EV / EBITDA | 13.35 | 13.67 | 11.16 | 11.41 | 8.96 | 9.13 | 7.98 | 7.74 | 10.29 | 7.93 | 9.24 |
| EV / EBIT | 17.22 | 24.02 | 20.57 | 16.01 | 12.79 | 12.08 | — | 15.69 | 16.19 | 18.13 | 12.44 |
| EV / FCF | — | 20.05 | 15.46 | 11.30 | 14.00 | 13.03 | 10.54 | 8.97 | 20.59 | 18.92 | 7.04 |
COR Profitability
Margins and return-on-capital ratios measuring operating efficiency
Cencora, Inc. earns an operating margin of 1.1%. Return on equity of 122.7% is exceptionally high, though this is partly amplified by negative book value driven by aggressive share buybacks. ROIC of 77.1% represents excellent returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.2% | 3.2% | 3.0% | 3.0% | 3.2% | 2.9% | 2.5% | 2.5% | 2.4% | 2.7% | 2.6% |
| Operating Margin | 1.1% | 1.1% | 1.0% | 0.9% | 1.2% | 1.3% | 1.1% | 1.0% | 1.0% | 1.3% | 1.1% |
| Net Profit Margin | 0.5% | 0.5% | 0.5% | 0.7% | 0.7% | 0.7% | -1.8% | 0.5% | 1.0% | 0.3% | 1.0% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 122.7% | 122.7% | 207.7% | 473.3% | 518.2% | 263.5% | -291.5% | 28.3% | 64.2% | 19.5% | 103.4% |
| ROA | 2.2% | 2.2% | 2.3% | 2.9% | 3.0% | 3.0% | -8.1% | 2.2% | 4.5% | 1.2% | 4.7% |
| ROIC | 77.1% | 77.1% | 93.0% | 69.9% | 58.1% | 112.0% | 114.5% | 32.3% | 31.0% | 43.3% | 43.3% |
| ROCE | 23.1% | 23.1% | 22.9% | 18.3% | 18.9% | 20.3% | 20.2% | 19.3% | 18.0% | 23.9% | 25.1% |
COR Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Cencora, Inc. carries a Debt/EBITDA ratio of 1.6x, which is manageable (48% below the sector average of 3.1x). Net debt stands at $3.3B ($7.7B total debt minus $4.4B cash). Interest coverage of 8.7x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 4.38 | 4.38 | 5.58 | 7.19 | 80.01 | 11.44 | — | 1.39 | 1.41 | 1.62 | 2.10 |
| Debt / EBITDA | 1.63 | 1.63 | 1.06 | 1.40 | 1.65 | 2.10 | 1.70 | 1.77 | 2.00 | 1.41 | 2.17 |
| Net Debt / Equity | — | 1.89 | 1.60 | 3.29 | 32.48 | 7.08 | — | 0.27 | 0.60 | 0.48 | 0.40 |
| Net Debt / EBITDA | 0.70 | 0.70 | 0.30 | 0.64 | 0.67 | 1.30 | -0.20 | 0.34 | 0.85 | 0.41 | 0.41 |
| Debt / FCF | — | 1.03 | 0.42 | 0.64 | 1.05 | 1.86 | -0.26 | 0.39 | 1.69 | 0.99 | 0.31 |
| Interest Coverage | 8.69 | 8.69 | 12.22 | 8.88 | 11.86 | 14.65 | 12.77 | 9.55 | 8.71 | 13.54 | 11.66 |
COR Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.90x is below 1.0, meaning current liabilities exceed current assets — though the company's $4.4B cash position helps mitigate short-term liquidity concerns. The quick ratio of 0.55x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.90 | 0.90 | 0.88 | 0.88 | 0.91 | 0.94 | 0.98 | 0.95 | 0.93 | 0.91 | 0.90 |
| Quick Ratio | 0.55 | 0.55 | 0.53 | 0.52 | 0.55 | 0.57 | 0.60 | 0.58 | 0.50 | 0.48 | 0.48 |
| Cash Ratio | 0.08 | 0.08 | 0.06 | 0.05 | 0.08 | 0.06 | 0.14 | 0.11 | 0.09 | 0.09 | 0.11 |
| Asset Turnover | — | 4.20 | 4.38 | 4.19 | 4.22 | 3.73 | 4.29 | 4.58 | 4.46 | 4.34 | 4.37 |
| Inventory Turnover | 15.19 | 15.19 | 15.01 | 14.58 | 14.85 | 13.52 | 14.70 | 15.83 | 13.75 | 13.00 | 13.34 |
| Days Sales Outstanding | — | 28.65 | 29.64 | 29.11 | 28.23 | 31.37 | 27.48 | 25.18 | 24.59 | 24.56 | 22.81 |
COR Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Cencora, Inc. returns 1.5% to shareholders annually — split between a 0.7% dividend yield and 0.7% buyback yield. The payout ratio of 28.1% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 2.6% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.7% | 0.7% | 0.9% | 1.1% | 1.4% | 1.5% | 1.7% | 1.9% | 1.6% | 1.7% | 1.6% |
| Payout Ratio | 28.1% | 28.1% | 27.6% | 22.8% | 23.1% | 23.8% | — | 39.6% | 20.1% | 77.3% | 20.2% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.6% | 2.5% | 3.3% | 4.7% | 5.9% | 6.2% | — | 4.9% | 8.2% | 2.0% | 7.8% |
| FCF Yield | 5.4% | 5.3% | 6.6% | 9.4% | 7.7% | 8.9% | 9.3% | 11.7% | 5.3% | 5.6% | 14.9% |
| Buyback Yield | 0.7% | 0.7% | 3.3% | 3.2% | 1.7% | 0.3% | 2.1% | 3.9% | 3.1% | 1.8% | 12.4% |
| Total Shareholder Yield | 1.5% | 1.4% | 4.2% | 4.3% | 3.1% | 1.8% | 3.8% | 5.8% | 4.8% | 3.5% | 14.0% |
| Shares Outstanding | — | $195M | $200M | $205M | $211M | $208M | $205M | $212M | $220M | $222M | $226M |
Peer Comparison
Compare COR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CORYou | $60B | 38.4 | 13.3 | 18.6 | 3.2% | 1.1% | 122.7% | 77.1% | 1.6 |
 MCK | $98B | 31.1 | 19.9 | 18.8 | 3.5% | 1.2% | — | 540.6% | 1.5 |
 CAH | $46B | 30.5 | 16.9 | 25.1 | 3.7% | 1.0% | — | 3378.7% | 3.0 |
 OMI | $171M | -0.2 | 1.7 | — | — | 1.0% | -2111.6% | 1.8% | 2.6 |
 HSIC | $9B | 22.7 | 11.3 | 14.9 | 29.1% | 5.7% | 8.3% | 7.1% | 3.4 |
 CVS | $103B | 58.1 | 12.5 | 13.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 PBM | $40M | -0.8 | — | — | — | — | -43.8% | -1.7% | — |
 UNH | $330B | 27.5 | 16.5 | 20.5 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 CI | $73B | 12.4 | 8.2 | 8.7 | 9.5% | 3.3% | 14.3% | 10.4% | 2.7 |
 HCA | $96B | 15.1 | 9.4 | 12.5 | 41.5% | 15.8% | — | 19.9% | 3.2 |
 DGX | $21B | 21.8 | 12.7 | 15.5 | 31.9% | 14.5% | 14.0% | 8.8% | 3.2 |
| Healthcare Median | — | 22.2 | 14.0 | 18.6 | 64.1% | -5.3% | -34.0% | -11.2% | 3.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
Full COR Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See COR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs COR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare COR vs MCK
Side-by-side business, growth, and profitability comparison vs McKesson Corporation.
Start ComparisonCOR — Frequently Asked Questions
Quick answers to the most common questions about buying COR stock.
What is Cencora, Inc.'s P/E ratio?
Cencora, Inc.'s current P/E ratio is 38.4x. The historical average is 24.0x. This places it at the 89th percentile of its historical range.
What is Cencora, Inc.'s EV/EBITDA?
Cencora, Inc.'s current EV/EBITDA is 13.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 10.3x.
What is Cencora, Inc.'s ROE?
Cencora, Inc.'s return on equity (ROE) is 122.7%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 61.3%.
Is COR stock overvalued?
Based on historical data, Cencora, Inc. is trading at a P/E of 38.4x. This is at the 89th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is Cencora, Inc.'s dividend yield?
Cencora, Inc.'s current dividend yield is 0.73% with a payout ratio of 28.1%.
What are Cencora, Inc.'s profit margins?
Cencora, Inc. has 3.2% gross margin and 1.1% operating margin.
How much debt does Cencora, Inc. have?
Cencora, Inc.'s Debt/EBITDA ratio is 1.6x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.